Elite Pharmaceuticals (ELTP) EV to EBIT (2010 - 2026)
Elite Pharmaceuticals' (ELTP) EV to EBIT stood at 6.09 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 61.1% from 15.65 a year earlier and down 40.8% from the prior quarter.
Elite Pharmaceuticals (ELTP) EV to EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' EV to EBIT came in at 3.60 as of Sep 30, 2026, down 75.4% year-over-year; for FY2026 (ended Mar 31, 2026), it was 7.28, down 68.9% from FY2025.
- Across earlier fiscal years, EV to EBIT came in at 23.38 in FY2025 (+65.2%), 14.15 in FY2024 (+134.7%), 6.03 in FY2023 (+40.3%) and 4.30 in FY2022 (-84.2%).
- The fiscal Q2 2027 figure is the lowest quarterly EV to EBIT since fiscal Q4 2023.
- On a year-over-year basis, EV to EBIT has declined for five consecutive quarters, with an average decline of 9.8% over the last eight quarters.
- Peak year-over-year performance for EV to EBIT in the last five years was growth of 702.2% in fiscal Q3 2024, against a decline of 84.2% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 10.28 (Q1 2027), 7.28 (Q4 2026) and 10.08 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,291.18 Bn | 1,264.79 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 686.56 Bn | 606.42 Bn | 17.30 Bn |
| 3 | AbbVie | 525.29 Bn | 493.30 Bn | 13.12 Bn |
| 4 | Merck | 362.24 Bn | 325.18 Bn | 13.19 Bn |
| 5 | Novartis Ag | 313.66 Bn | 286.90 Bn | - |
| 6 | Astrazeneca | 286.68 Bn | 260.20 Bn | 13.26 Bn |
| 7 | Amgen | 253.44 Bn | 205.10 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.62 Bn | 185.73 Bn | 6.73 Bn |
| 9 | Pfizer | 165.41 Bn | 112.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 397.46 Mn | 270.87 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.09 |
| Jun 30, 2026 | 10.28 |
| Mar 31, 2026 | 7.28 |
| Dec 31, 2025 | 10.08 |
| Sep 30, 2025 | 15.65 |
| Jun 30, 2025 | 20.24 |
| Mar 31, 2025 | 23.38 |
| Dec 31, 2024 | 46.66 |
| Sep 30, 2024 | 27.83 |
| Jun 30, 2024 | 15.69 |
| Mar 31, 2024 | 14.15 |
| Dec 31, 2023 | 20.42 |
| Sep 30, 2023 | 16.11 |
| Jun 30, 2023 | 7.30 |
| Mar 31, 2023 | 6.03 |
| Dec 31, 2022 | 2.55 |
| Sep 30, 2022 | 4.60 |
| Jun 30, 2022 | 6.00 |
| Mar 31, 2022 | 4.30 |
| Dec 31, 2021 | 7.31 |
Elite Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();